Autism, Epilepsy, and Synaptopathies: a Not Rare Association

Overview

Journal Neurol Sci

Specialty Neurology

Date 2017 Apr 30

PMID 28455770

Citations 49

Authors

Roberto Keller

Roberta Basta

Luana Salerno

Maurizio Elia

Affiliations

Soon will be listed here.

Abstract

Autism spectrum disorders (ASD) are neurodevelopmental disorders typically diagnosed in childhood, characterized by core social dysfunction, rigid and repetitive behaviors, restricted interests, and abnormal sensorial sensitivity. ASD belong to multifactorial diseases: both genetic and environmental factors have been considered as potential risk factors for their onset. ASD are often associated with neurological conditions: the co-occurrence of epilepsy is well documented and there is also evidence of a higher prevalence of EEG abnormalities with 4-86% of individuals with ASD presenting epileptiform or not epileptiform EEG abnormalities. The presence of epilepsy in people with ASD may be determined by several structural alterations, genetic conditions, or metabolic dysfunctions, known to play a role in the emergence of both epilepsy and autism. The purpose of this article is to discuss precisely such latter cause of the autism-epilepsy association, focusing specifically on those "synaptic genes," whose mutation predisposes to both the diseases.

Citing Articles

A Massively Parallel CRISPR-Based Screening Platform for Modifiers of Neuronal Activity.

Boggess S, Gandhi V, Tsai M, Marzette E, Teyssier N, Yu-Ying Chou J bioRxiv. 2025; .

PMID: 39990495 PMC: 11844385. DOI: 10.1101/2024.02.28.582546.

Harnessing the potential of human induced pluripotent stem cells, functional assays and machine learning for neurodevelopmental disorders.

Yang Z, Teaney N, Buttermore E, Sahin M, Afshar-Saber W Front Neurosci. 2025; 18:1524577.

PMID: 39844857 PMC: 11750789. DOI: 10.3389/fnins.2024.1524577.

Exploring the Landscape of Pre- and Post-Synaptic Pediatric Disorders with Epilepsy: A Narrative Review on Molecular Mechanisms Involved.

Scorrano G, Di Francesco L, Di Ludovico A, Chiarelli F, Matricardi S Int J Mol Sci. 2024; 25(22).

PMID: 39596051 PMC: 11593774. DOI: 10.3390/ijms252211982.

Burden of status epilepticus: prognosis and cost driving factors, insight from a nationwide retrospective cohort study of the French health insurance database.

Calonge Q, Le Gac F, Chavez M, Degremont A, Quantin C, Tubach F J Neurol. 2024; 271(10):6761-6772.

PMID: 39177750 DOI: 10.1007/s00415-024-12589-6.

Mechanisms of neurodevelopmental toxicity of topiramate.

Steele J, Krishnan V, Finnell R Crit Rev Toxicol. 2024; 54(7):465-475.

PMID: 38995641 PMC: 11296906. DOI: 10.1080/10408444.2024.2368552.

References

Johannessen C, Reczek E, James M, Brems H, Legius E, Cichowski K . The NF1 tumor suppressor critically regulates TSC2 and mTOR. Proc Natl Acad Sci U S A. 2005; 102(24):8573-8. PMC: 1142482. DOI: 10.1073/pnas.0503224102. View

Peca J, Feliciano C, Ting J, Wang W, Wells M, Venkatraman T . Shank3 mutant mice display autistic-like behaviours and striatal dysfunction. Nature. 2011; 472(7344):437-42. PMC: 3090611. DOI: 10.1038/nature09965. View

Russo E, Follesa P, Citraro R, Camastra C, Donato A, Isola D . The mTOR signaling pathway and neuronal stem/progenitor cell proliferation in the hippocampus are altered during the development of absence epilepsy in a genetic animal model. Neurol Sci. 2014; 35(11):1793-9. DOI: 10.1007/s10072-014-1842-1. View

Hamada N, Ito H, Iwamoto I, Morishita R, Tabata H, Nagata K . Role of the cytoplasmic isoform of RBFOX1/A2BP1 in establishing the architecture of the developing cerebral cortex. Mol Autism. 2015; 6:56. PMC: 4617638. DOI: 10.1186/s13229-015-0049-5. View

Curatolo P, Moavero R . mTOR Inhibitors in Tuberous Sclerosis Complex. Curr Neuropharmacol. 2013; 10(4):404-15. PMC: 3520048. DOI: 10.2174/157015912804143595. View

Wang J, Barstein J, Ethridge L, Mosconi M, Takarae Y, Sweeney J . Resting state EEG abnormalities in autism spectrum disorders. J Neurodev Disord. 2013; 5(1):24. PMC: 3847481. DOI: 10.1186/1866-1955-5-24. View

Yasuhara A . Correlation between EEG abnormalities and symptoms of autism spectrum disorder (ASD). Brain Dev. 2010; 32(10):791-8. DOI: 10.1016/j.braindev.2010.08.010. View

Novarino G, El-Fishawy P, Kayserili H, Meguid N, Scott E, Schroth J . Mutations in BCKD-kinase lead to a potentially treatable form of autism with epilepsy. Science. 2012; 338(6105):394-7. PMC: 3704165. DOI: 10.1126/science.1224631. View

Greco B, Manago F, Tucci V, Kao H, Valtorta F, Benfenati F . Autism-related behavioral abnormalities in synapsin knockout mice. Behav Brain Res. 2013; 251:65-74. PMC: 3730181. DOI: 10.1016/j.bbr.2012.12.015. View

10.

Talos D, Sun H, Zhou X, Fitzgerald E, Jackson M, Klein P . The interaction between early life epilepsy and autistic-like behavioral consequences: a role for the mammalian target of rapamycin (mTOR) pathway. PLoS One. 2012; 7(5):e35885. PMC: 3342334. DOI: 10.1371/journal.pone.0035885. View

11.

Guerrini R, Parrini E . Epilepsy in Rett syndrome, and CDKL5- and FOXG1-gene-related encephalopathies. Epilepsia. 2012; 53(12):2067-78. DOI: 10.1111/j.1528-1167.2012.03656.x. View

12.

Lyu J, Yuan B, Cheng T, Qiu Z, Zhou W . Reciprocal regulation of autism-related genes MeCP2 and PTEN via microRNAs. Sci Rep. 2016; 6:20392. PMC: 4740767. DOI: 10.1038/srep20392. View

13.

Curran S, Ahn J, Grayton H, Collier D, Ogilvie C . NRXN1 deletions identified by array comparative genome hybridisation in a clinical case series - further understanding of the relevance of NRXN1 to neurodevelopmental disorders. J Mol Psychiatry. 2014; 1(1):4. PMC: 4223877. DOI: 10.1186/2049-9256-1-4. View

14.

Jeyabalan N, Clement J . SYNGAP1: Mind the Gap. Front Cell Neurosci. 2016; 10:32. PMC: 4753466. DOI: 10.3389/fncel.2016.00032. View

15.

McMahon J, Yu W, Yang J, Feng H, Helm M, McMahon E . Seizure-dependent mTOR activation in 5-HT neurons promotes autism-like behaviors in mice. Neurobiol Dis. 2014; 73:296-306. PMC: 4394017. DOI: 10.1016/j.nbd.2014.10.004. View

16.

Miano S, Bruni O, Arico D, Elia M, Ferri R . Polysomnographic assessment of sleep disturbances in children with developmental disabilities and seizures. Neurol Sci. 2010; 31(5):575-83. DOI: 10.1007/s10072-010-0291-8. View

17.

Stafstrom C, Benke T . Autism and Epilepsy: Exploring the Relationship Using Experimental Models. Epilepsy Curr. 2015; 15(4):206-10. PMC: 4532234. DOI: 10.5698/1535-7511-15.4.206. View

18.

Paonessa F, Latifi S, Scarongella H, Cesca F, Benfenati F . Specificity protein 1 (Sp1)-dependent activation of the synapsin I gene (SYN1) is modulated by RE1-silencing transcription factor (REST) and 5'-cytosine-phosphoguanine (CpG) methylation. J Biol Chem. 2012; 288(5):3227-39. PMC: 3561544. DOI: 10.1074/jbc.M112.399782. View

19.

Frye R . Metabolic and mitochondrial disorders associated with epilepsy in children with autism spectrum disorder. Epilepsy Behav. 2014; 47:147-57. DOI: 10.1016/j.yebeh.2014.08.134. View

20.

Marchese M, Conti V, Valvo G, Moro F, Muratori F, Tancredi R . Autism-epilepsy phenotype with macrocephaly suggests PTEN, but not GLIALCAM, genetic screening. BMC Med Genet. 2014; 15:26. PMC: 3941568. DOI: 10.1186/1471-2350-15-26. View